Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety

View source ↗

Summary

This clinical trial update examines the incidence of postoperative serum hyperamylasemia after pancreatectomy and its potential impact on postoperative outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Technische Universität Dresden | Conditions: Pancreatectomy, Hyperamylasemia | Status: RECRUITING